RNAi agents, compositions and Methods of Use thereof for treating Diseases associated with transthyretin (TTR). (Divisional Application 201401291)

• 收藏
• 分享

专利权人:

ALNYLAM PHARMACEUTICALS; INC

发明人:

CHARISSE, Klaus,MAIER, Martin,ZIMMERMANN, Tracy,RAJEEV, Kallanthottathil, G.,MANOHARAN, Muthiah,KUCHIMANCHI, Satyanarayana,CHARISSE KLAUS,MAIER MARTIN,ZIMMERMANN TRACY,RAJEEV KALLANTHOTTATHIL G,MANOHARAN MUTHIAH,KUCHIMANCHI, Sa

申请号：

CL2018002703

公开号：

CL2018002703A1

申请日:

2018.09.24

申请国别(地区):

CL

年份:

2018

代理人:

摘要：

The present Invention provides RNAi agents, including agents RNAi Double Strand,That target Gene of transthyretin (TTR) and Methods for using such agents of RNAi to Treat or prevent Diseases associated with TTR.<；p>；LA PRESENTE INVENCIÓ；N PROPORCIONA AGENTES DE IARN, POR EJEMPLO, AGENTES DE IARN DE DOBLE HEBRA, QUE SE DIRIGEN AL GEN DE LA TRANSTIRETINA (TTR) Y MÉ；TODOS PARA UTILIZAR DICHOS AGENTES DE IARN PARA TRATAR O PREVENIR ENFERMEDADES ASOCIADAS A TTR.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/